The biomarker potential of using various lipids fractions for predicting risk of acute myocardial infarction (AMI) is controversial.We therefore compared the lipid profiles, including serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL) and triglycerides (TG), in 67AMI patients. Patients included 28 STEMI (STelevatedmyocardialinfarction)patients,39NSTEMI(non-ST-elevatedmyocardialinfarction)patientsand25patientswithchestpain.
Introduction
The pathogenesis of acute myocardial infarction (AMI) is multifactorial; however, several studies have implicated impaired lipid metabolism as one of the crucial factors in the development of this disease. Kumar et al 1 observedsignificantlyhighertotalcholesterol(TC)andtriglyceride(TG)levelsandlower high-densitylipoproteincholesterol(HDL)levelsin AMI patients. In a series of 50 maleAMI patients, serum low-density lipoprotein cholesterol (LDL) levels and the ratio of LDL to HDL were not significantlydifferentamongthetwogroups;however, serum HDL levels were significantly decreased in AMI group. 2 The risk ofAMI was associated with anincreaseinLDLandadecreaseinHDL,inboth Asians and non-Asians. 3 Lower concentrations of serumHDLandhigherserumTGwerefoundtobe independent risk factors, while serum LDL was not associated with AMI. 4 Woo et al 5 observed higher meanTC,LDL,andTG,aswellaslowermeanHDL inAMI patients; high HDL was among the protective factors. Lehto et al 6 didnotfindanydifferencein meanserumTClevelsbetweentheAMIpatientsand controls,whereasmeanHDLwassignificantlylower in theAMI group. The cardiac marker, troponin T, hasbeenpositivelycorrelatedwithTC,LDL,andTG andnegativelycorrelatedwithHDL. 7 The management of dyslipidemia after myocardial infarctionisanimportantaspectofpost-myocardial infarction care. 8 Using the bivariate and multivariate Coxproportionalhazardsanalysistoidentifyindependentpredictorsofsubsequentmajoradversecoronary events (hospitalization for AMI or acute coronary syndrome), it was found that HDL predicted major adverse coronary events, which in turn provided support for interventions targeting HDL for cardiovascular risk reduction. 9 Another Cox proportional hazards model has revealed that plasma HDL-but not LDL-predicts the risk of recurrent cardiovascular events over the ensuing 16 weeks. Even LDL reduction does not account for the clinical risk reductionwithatorvastatintreatmentafteracutecoronary syndrome(ACS). 10 Li et al 11 haveshownthatthecases with low HDL level had rates of AMI events and CHD mortality similar to those of the entire group, includinghyperlipidemia.However,AMIattacksand deathsdecreasedsignificantlyatthenormalandhigh HDLlevels,indicatingthatprotectiveeffectofHDL against coronary artery disease is more prominent in peoplewithlowlipidlevel.
The above literature clearly indicates an important roleoflipidsmetabolisminAMI.However,thebiomarkervalueofvariouscomponentsoflipidsprofileis notclearduetoconflictingfindingsinvarious studies. WethereforecomparedthelipidprofilesofAMIand chestpainpatientswithrespecttonormalsubjects.In addition,wealsostudiedtheroleofinflammationin AMIandevaluateditscorrelationwithlipidprofiles.
Patients and Methods
This prospective study was conducted on 67 AMI patients and 25 patients with chest pain admitted to Prince Sultan Cardiac Center and King Khalid UniversityHospital,Riyadh,SaudiArabia.TheAMI patients were classified into STEMI (ST-elevated myocardial infarction, N = 28) and NSTEMI (non-ST-elevated myocardial infarction, N = 39). Mean ages of STEMI, NSTEMI, and chest pain patients were56.21±12.65years,61.98±10.83years,and 53.83±13.75years,respectively( Table 1) . We also included 54 age-and gender-matched controls for comparison.
The diagnosis of myocardial infarction required the presence at least two of the following criteria: (i) history of characteristic prolonged ($30 minutes) pain or discomfort, (ii) creatine kinase (CK) levels exceeding twice the upper limit of normal (or CK-MB$ 50%oftotalCK);(iii)presenceofnew QwavesornewabnormalST-Tfeatures. 12 Patients with STEMI were classified on the basis of the Venousbloodwascollectedafterovernightfasting from all the subjects in serum separator Vaccutainer tubes. The levels of serum total cholesterol, lipoproteins,triglycerides,andhs-CRPwereanalyzedusingan Autoanalyzer(Roche,Germany).Thedatawereevaluated by one-way analysis of variance (ANOVA) followed byDunnett'smultiplecomparisontestusingSPSSstatisticalpackageversion17.Pearson'sandSpearman's testswereusedforcorrelationanalysisofcontinuous and categorical variables respectively. P values ,0.05 wereconsideredasstatisticallysignificant.
Results
The characteristics of patients and controls are summarized in Table 1 . The family history of associated diseases was noted for hypertension (3/28 STEMI, 1/39 NSTEMI and 5/25 chest pain) and CAD and hypertension(1STEMI,2NSTEMIand2chestpain). There were significant decreases in TC (ANOVA F = 13.848, P = 0.000), LDL (ANOVA F = 6.520, P =0.000),andHDL(ANOVAF=6.027,P =0.001) levels in both STEMI and NSTEMI patients, as comparedtonormalsubjects;however,patientswith chestpaindidnotshowanysignificantchangeinthese lipids (Table2andFig.1).SerumTGlevelsdidnot differsignificantlyamongSTEMI,NSTEMI,orchest painpatients,ascomparedtocontrolgroup(ANOVA F =0.061,P =0.980)(Table2andFig. 1). The commonlyusedinformativelipidsratios-includingTC/ HDL,LDL/HDL,andTG/HDL-didnotdiffersignificantlyamongdifferentgroups (Fig.2) .
Thereweresignificantincreasesinserumhs-CRP levelsinSTEMIandNSTEMIpatientsascomparedto controlgroup(ANOVAF=3.213,P =0.025) (Fig.3) . Serumhs-CRPshowedsignificantinversecorrelation withHDL(R= −0.193,P =0.042).However,hs-CRP wasnotcorrelatedwithTC(R= −0.010,P =0.910), LDL (R = 0.065, P = 0.497) and TG (R = −0.031, P =0.733).
Agewassignificantlyandinverselycorrelatedwith TC(R= −0.144,P =0.025)andLDL(R= −0.164, P = 0.015) and directly correlated with hs-CRP (R=0.193,P =0.022)(Table3).Therewasnosignificant correlation between age and HDL and TG. Bodymassindex,gender,andsmokingdidnotshow any significant correlation with lipids or hs-CRP (Table3).Wedidnotobserveanysignificantcorrelation between systolic blood pressure and lipids or hs-CRP; however, diastolic blood pressure showed significantcorrelationwithTC(R=0.198,P =0.013) andLDL(R=0.162,P =0.046)butnotwithHDL, TGorhs-CRP(Table3).
Discussion
OurresultsshowedsignificantdecreasesinTC,LDL, and HDL levels inAMI patients (Table 2) . Gorecki et al 14 observed higher levels of TC and LDL in patientswithcomplicatedversusthosewithuncomplicatedclinicalcourseofinfarction,suggestinghigher levels of these biomarkers during the first 24 hours of AMI have a strong negative prognostic value. Akosah et al 15 reported acceptable or optimal LDL levels in a series of 183 young adults experiencing AMI.Gazianoetal 8 foundthatthemeanTCandLDL levelsweresignificantlylowerwhilein-hospitalthan levels2 to 3 monthslater;however,froma clinical perspective, in-hospital levels can be used to guide decisionsregardinglipid-loweringtherapy,whichcan begin in the immediate post-MI setting. In a series of34AMIpatients,onthefirstdayafteradmission there were significant decreases inTC (14.1%) and LDL (14.4%), as well as insignificant decreases in HDL(9.3%)andTG(19.5%). 16 Onthebasisoflipid profiledataof97patientswithNSTEMIandunsta-bleangina,ithasbeenconcludedthatHDLlevel(as opposedtoLDLandTG)addsprognosticvaluetothe predictionofin-hospitalrecurrenteventsduringnon-ST-elevation acute coronary syndromes. 17 Rosoklija et al 18 have followed-up the HDL cholesterol levels in STEMI patients from 24 hours to 3 months and concluded that the optimal times for determining the HDLlevelarethefirst24hoursoftheactualevent; thisisduetothefactthatinthefirst24hoursthere is a relevant decrease of the HDL cholesterol level in the blood. The cause of reduced serum lipids in AMI patients in our study is not clear. It could be related to dietary modifications or due to metabolic changesduringacutecrisis.Nevertheless,thelipids data negate the general conception that dietary lipids restrictions may prevent the risk of AMI.
High serum levels of HDL are associated with reduced risk for the development of atherosclerotic disease.HDLparticlesarebelievedtobeantiatherogenic, secondary to their capacity to drive reverse cholesterol transport and antagonize pathways of inflammation, thrombosis, and oxidation. The majority of patients in both the primary and secondary prevention settings continue to experience significant residual risk for acute cardiovascular events, even when their LDL cholesterol is lowered aggressively via a combination of lifestyle modification and pharmacologic intervention. 19 Al Aqeel et al 20 have observed that HDL appears to be the main lipid risk factor in patients presenting withAMI in Kuwaiti patients, suggesting that primary prevention strategies should focus on treatment modalities that increase HDL. In an in-vivo mouse model of myocardial ischemia/reperfusion, ithasbeenobservedthatHDLanditssphingolipid component, sphingosine-1-phosphate, dramatically attenuatedtheinfarctsize,suggestingarapidtherapeuticelevationofplasmaHDLlevelsmaybebeneficial in patients at high risk of acute myocardial ischemia. 21 There is an increased focus on targeting andtreatinglowserumlevelsofHDLinaneffortto furtherreduceriskforcardiovascularevents,including myocardial infarction. 19 Inourstudy,noneofthelipidsratioswerefoundto be informative in prediction of AMI (Fig.2) .Onthe contrary,LDL/HDLratiohasbeensuggestedtobean independent predictor for AMI in the Japanese rural population.
22 Goswamietal 23 have suggested that the apo-B/apo-AIratioisabetterdiscriminatorofCAD riskintheatherosclerosis-pronepopulationthanany of the conventional lipid ratios such asTC/HDL or LDL/HDL. Karthikeyan et al 3 have also found the strongest association occurs between ApoB/ApoA1 and the risk of AMI. McQueen et al 24 have observed the highest population-attributable risk (PAR) with the ratio of ApoB/ApoA1 (54%) compared to the PAR associated with the ratios of LDL/HDL (37%) andTC/HDL(32%).
We observed significant increase in hs-CRP levels in AMI patients (Fig. 3) , which is in agreementwithearlierreports. [25] [26] [27] hs-CRPisasensitive markerofinflammationandapotentialindependent predictor of cardiovascular disease as it may play a role in the development of atherosclerosis; additionally,italsoadverselyaffectsmortality. 28 Suzuki et al 29 have found nearly equivalent systemic and coronary levels of hs-CRP in AMI patients. They also observed a positive correlation between systemichs-CRPandcoronaryplaquearea,suggesting an important link between systemic and coronary levelsof inflammation.Theirobservationsarealso associated with vulnerable coronary morphology in the development of acute coronary syndromes.
29
Higher baseline hs-CRP level showed significant associationwith12-monthall-causemortality,independentofotherprognosticmarkers,inoverweight or obese AMI patients. 30 Thefindingsofacrosssectionalstudyof188patientswithSTEMIsuggested that plasma hs-CRP could be useful for prediction of development of heart failure in AMI patients.
31
Elevated serum hs-CRP levels in patients with AMI ,6hoursmayportendvulnerableplaquerup-ture. 32 Thepatientswithpersistent,severe,treatmentunresponsive unstableangina(UA)hadsignificantly higherCRPlevelsandahigherincidenceofclinical eventsthanpatientswithtreatment-responsiveUA, suggesting an important prognostic value of plasma CRP. 33 However, there was no correlation between plasma CRP and TC or HDL in UA patients. 33 A significantinversecorrelationbetweenhs-CRPand HDL(butnotwithotherlipidfractions),asobserved inourstudy,indicatestheco-existenceofinflammation and impaired lipid metabolism in AMI patients. The correlation data showed that serum HDL was not affected by age, gender, BMI, smoking, and blood pressure (Table3).AlthoughthelevelsofhsCRPweredirectlycorrelatedwithage,hs-CRPwas notinfluencedbygender,BMI,smoking,andblood pressure (Table3).
Conclusion
OurfindingssuggestthatreductioninserumcholesteroldoesnotpreventtheriskofAMI.Therewasa significantincreaseinsystemicinflammationinAMI patients, inversely correlated with HDL levels, suggestinganimportantroleofinflammatorymediators inAMI.Thus,adecreaseinserumHDLandincrease in hs-CRP strongly predispose the risky individuals to the event of AMI. We emphasize the importance ofHDLandhs-CRPmeasurementsintheassessment ofacombinedlipido-inflammatoryriskfactorforthe screening of high risk individuals and the prognosis of AMI. and that they have permission from rights holders to reproduce any copyrighted material. Any disclosuresaremadeinthissection.Theexternalblindpeer reviewersreportnoconflictsofinterest.
